---
figid: PMC9495514__antioxidants-11-01705-g010
pmcid: PMC9495514
image_filename: antioxidants-11-01705-g010.jpg
figure_link: /pmc/articles/PMC9495514/figure/antioxidants-11-01705-f010/
number: Figure 10
figure_title: ''
caption: 'Effect of ICS II on PA-induced injury in PPARα/γ-KO HepG2 cells. (a) Representative
  western blot of PPARα and PPARγ protein expressions after knockout of PPARα/γ. (b)
  Quantitation of PPARα/γ protein expressions (n = 6). (c) Oil red O staining of HepG2
  cells (×400, scale bar = 50 μm). Treatment with or without ICS II (20 μM) in PPARα/γ-KO
  HepG2 cells and WT HepG2 cells. (d) Quantitation of Oil red O staining (n = 5).
  (e) LDH level. Treatment with or without ICS II (20 μM) in PPARα/γ-KO HepG2 cells
  and WT HepG2 cells. (n = 6). Data were expressed as mean ± SEM. ** p < 0.01 versus
  control group (WT); #p < 0.05 and ##p < 0.01 versus PA 300 group (WT); aap < 0.01
  versus control group (PPARα/γ-KO); bbp < 0.01 versus PA 300 group (PPARα/γ-KO);
  &&p < 0.01 versus PA 300 group (WT); $p < 0.05 and $$p < 0.01 versus PA 300 + ICS
  II 20 group (WT); @@p < 0.01 versus PA 300 + Saro 40 group (WT).'
article_title: 'Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ:
  Involvement of ROS/NF-κB/IRS1 Signaling Pathway.'
citation: Yiqi Li, et al. Antioxidants (Basel). 2022 Sep;11(9):1705.
year: '2022'

doi: 10.3390/antiox11091705
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI

keywords:
- Icariside II
- Type 2 diabetes mellitus
- peroxisome proliferator-activated receptors α and γ
- oxidative stress
- inflammation

---
